scholarly journals Corrigendum: IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation

2020 ◽  
Vol 11 ◽  
Author(s):  
Xun Liu ◽  
Fei Li ◽  
Hongxia Niu ◽  
Lan Ma ◽  
Jianzhu Chen ◽  
...  
Cell Reports ◽  
2019 ◽  
Vol 29 (11) ◽  
pp. 3564-3579.e5 ◽  
Author(s):  
Shannon L. Russell ◽  
Dirk A. Lamprecht ◽  
Tawanda Mandizvo ◽  
Terrence T. Jones ◽  
Vanessa Naidoo ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Frank Camacho ◽  
Ernesto Moreno ◽  
Luis F. Garcia-Alles ◽  
Glay Chinea Santiago ◽  
Martine Gilleron ◽  
...  

2005 ◽  
Vol 73 (2) ◽  
pp. 1097-1105 ◽  
Author(s):  
Lakshmi Ramachandra ◽  
Jamie L. Smialek ◽  
Sam S. Shank ◽  
Marilyn Convery ◽  
W. Henry Boom ◽  
...  

ABSTRACT Control of Mycobacterium tuberculosis infection requires CD4 T-cell responses and major histocompatibility complex class II (MHC-II) processing of M. tuberculosis antigens (Ags). We have previously demonstrated that macrophages process heat-killed (HK) M. tuberculosis more efficiently than live M. tuberculosis. These observations suggested that live M. tuberculosis may inhibit Ag processing by inhibiting phagosome maturation or that HK M. tuberculosis may be less resistant to Ag processing. In the present study we examined the correlation between M. tuberculosis viability and phagosome maturation and efficiency of Ag processing. Since heat treatment could render M. tuberculosis Ags more accessible to proteolysis, M. tuberculosis was additionally killed by antibiotic treatment and radiation. Processing of HK, live, radiation-killed (RadK), or rifampin-killed (RifK) M. tuberculosis in activated murine bone marrow macrophages was examined by using an I-Ab-restricted T-cell hybridoma cell line (BB7) that recognizes an epitope derived from Ag 85B. Macrophages processed HK M. tuberculosis more rapidly and efficiently than they processed live, RadK, or RifK M. tuberculosis. Live, RadK, and RifK M. tuberculosis cells were processed with similar efficiencies for presentation to BB7 T hybridoma cells. Furthermore, phagosomes containing live or RadK M. tuberculosis expressed fewer M. tuberculosis peptide-MHC-II complexes than phagosomes containing HK M. tuberculosis expressed. Since only live M. tuberculosis was able to prevent acidification of the phagosome, our results suggest that regulation of phagosome maturation does not explain the differences in processing of different forms of M. tuberculosis. These findings suggest that the mechanisms used by M. tuberculosis to inhibit phagosomal maturation differ from the mechanisms involved in modulating phagosome Ag processing.


2010 ◽  
Vol 207 (10) ◽  
pp. 2175-2186 ◽  
Author(s):  
Julien Fourcade ◽  
Zhaojun Sun ◽  
Mourad Benallaoua ◽  
Philippe Guillaume ◽  
Immanuel F. Luescher ◽  
...  

The paradoxical coexistence of spontaneous tumor antigen–specific immune responses with progressive disease in cancer patients furthers the need to dissect the molecular pathways involved in tumor-induced T cell dysfunction. In patients with advanced melanoma, we have previously shown that the cancer-germline antigen NY-ESO-1 stimulates spontaneous NY-ESO-1–specific CD8+ T cells that up-regulate PD-1 expression. We also observed that PD-1 regulates NY-ESO-1–specific CD8+ T cell expansion upon chronic antigen stimulation. In the present study, we show that a fraction of PD-1+ NY-ESO-1–specific CD8+ T cells in patients with advanced melanoma up-regulates Tim-3 expression and that Tim-3+PD-1+ NY-ESO-1–specific CD8+ T cells are more dysfunctional than Tim-3−PD-1+ and Tim-3−PD-1− NY-ESO-1–specific CD8+ T cells, producing less IFN-γ, TNF, and IL-2. Tim-3–Tim-3L blockade enhanced cytokine production by NY-ESO-1–specific CD8+ T cells upon short ex vivo stimulation with cognate peptide, thus enhancing their functional capacity. In addition, Tim-3–Tim-3L blockade enhanced cytokine production and proliferation of NY-ESO-1–specific CD8+ T cells upon prolonged antigen stimulation and acted in synergy with PD-1–PD-L1 blockade. Collectively, our findings support the use of Tim-3–Tim-3L blockade together with PD-1–PD-L1 blockade to reverse tumor-induced T cell exhaustion/dysfunction in patients with advanced melanoma.


Sign in / Sign up

Export Citation Format

Share Document